EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?-Reference-Cited by-同舟云学术

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Published:2014-04 Issue:1 Volume:84 Page:86-91
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hendriks L.E.L.,Smit E.F.,Vosse B.A.H.,Mellema W.W.,Heideman D.A.M.,Bootsma G.P.,Westenend M.,Pitz C.,de Vries G.J.,Houben R.,Grünberg K.,Bendek M.,Speel E.-J.M.,Dingemans A.-M.C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas;Johnson;Cancer,2013

4. Brain metastases: the HER2 paradigm;Lin;Clin Cancer Res,2007

5. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer;Eichler;Neuro Oncol,2010

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer;Frontiers in Oncology;2024-08-26

3. A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases;International Journal of Molecular Sciences;2024-06-26

4. Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study;Cancer Medicine;2024-04

5. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter study;2024-02-15